Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Five Prime Therapeutics, Inc. bouchon mache

Volim nan komès stock Five Prime Therapeutics, Inc. jodi a ak istwa a nan lèt majiskil nan Five Prime Therapeutics, Inc. Depi nan kòmansman an nan komès nan FPRX aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Five Prime Therapeutics, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Five Prime Therapeutics, Inc. se 1 769 735 936 US dola.
+465 536 $ (+0.026%)
chanjman nan lèt majiskil depi yè

Five Prime Therapeutics, Inc. kapitalize mache an dola jodi a. Chak jou, nou anrejistre yon chanjman nan majiskil Five Prime Therapeutics, Inc.. Enfòmasyon nan Five Prime Therapeutics, Inc. majiskil yo te pran nan sous louvri. Five Prime Therapeutics, Inc. mache kap jodi a se $ 1 769 735 936.

Five Prime Therapeutics, Inc. volim nan komès

Jodi a volim nan komès de aksyon Five Prime Therapeutics, Inc. montan 935 834 US dola.
+213 079 $ (+29.48%)
chanjman nan volim nan komès depi yè

Five Prime Therapeutics, Inc. volim komès jodi a - 935 834 dola ameriken. Tablo chak jou nan Five Prime Therapeutics, Inc. komès volim prezante sou sit entènèt nou an. Five Prime Therapeutics, Inc. komès nan tan reyèl hands sou pi echanj valè stock, sit entènèt nou an montre volim komès la chak jou nan Five Prime Therapeutics, Inc.. Five Prime Therapeutics, Inc. majiskil grandi pa $ 465 536.

Montre:
Pou

Five Prime Therapeutics, Inc. mache bouchon tablo

Sou semèn lan, Five Prime Therapeutics, Inc. majiskil chanje pa 0.18%. Chanjman nan majiskil Five Prime Therapeutics, Inc. pou chak mwa se 0%. 0% chak ane - yon chanjman nan lèt majiskil sou mache Five Prime Therapeutics, Inc.. Jodi a, Five Prime Therapeutics, Inc. majiskil egal a 1 769 735 936 dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Five Prime Therapeutics, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
15/04/2021 1 769 735 936 $
14/04/2021 1 769 270 400 $
13/04/2021 1 767 873 024 $
12/04/2021 1 767 174 528 $
09/04/2021 1 766 941 568 $
08/04/2021 1 766 243 072 $
07/04/2021 1 766 476 032 $

Five Prime Therapeutics, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Five Prime Therapeutics, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Five Prime Therapeutics, Inc. se kantite total tout tranzaksyon ak aksyon FPRX achte ak vann pandan dat la chwazi a.
15/04/2021 935 834 $
14/04/2021 722 755 $
13/04/2021 557 445 $
12/04/2021 285 668 $
09/04/2021 646 661 $
08/04/2021 627 006 $
07/04/2021 998 577 $

15/04/2021 Five Prime Therapeutics, Inc. majiskil egal a 1 769 735 936 dola ameriken. Lèt majiskil sou mache Five Prime Therapeutics, Inc. montan pou 1 769 270 400 dola ameriken nan 14/04/2021. Lèt majiskil sou mache Five Prime Therapeutics, Inc. montan pou 1 767 873 024 dola ameriken nan 13/04/2021. 12/04/2021 Five Prime Therapeutics, Inc. majiskil egal a 1 767 174 528 dola ameriken.

09/04/2021 Five Prime Therapeutics, Inc. lèt majiskil mache egal a 1 766 941 568 dola ameriken. Lèt majiskil sou mache Five Prime Therapeutics, Inc. nan 08/04/2021 montan pou 1 766 243 072 dola ameriken. 07/04/2021 Five Prime Therapeutics, Inc. majiskil egal a 1 766 476 032 dola ameriken.

Lèt majiskil Five Prime Therapeutics, Inc. jodi a se 1 769 735 936 $. Kapitalizasyon sou mache a nan Five Prime Therapeutics, Inc. te chanje a +0.026% konpare ak yè. Volim komèsyal de aksyon FPRX nan Five Prime Therapeutics, Inc. nan dènye jou komès montan pou 935 834 $. Volim komèsyal de aksyon de Five Prime Therapeutics, Inc. chanje pou +29.48% konpare ak jou komès anvan an.

Pri a de aksyon Five Prime Therapeutics, Inc.

Finans Five Prime Therapeutics, Inc.